Menstrual effects Jul 95 Neur 1995;45:1028
" Nov 95 Mov Disord 1993;8:240-241
Metaclopramide (Reglan)Jan 96 JAMA 1995;274:1780-82
Metals, exposure to Apr 97 Neur 1997;48:650-658
Methylsalsolinol Aug 96 Ann Neur 1996;40:119-122
Metronome Jun 96 Lancet 11 May 1996:1337
Migraine, DA and May 97 J Clin Neuropharm 1997;20:36-41
Mimics of PD Oct 95 Arch Neur 1995;58:294-298
" Oct 95 Brain 1995;118:951-958
" Apr 96 BMJ 16 Mar 1996:724
Mitochondria Sep 95 Science News 5 Aug 1995;84
" Feb 96 Neur 1995;45:2097-2099
" Feb 97 Mov Disord 1997;12:3-16
Mortality Apr 95 J Neur N'surg Psych 1995;58:293-299
" Apr 97 Arch Neur 1997;54:260-264
Motor cognition Oct 97 Brain 1997;120:1339-53
" " Oct 97 Brain 1997;120:1355-75
" fluctuations Aug 96 J Neur N'surg Psych 1996;61:634-637
" skill learning Oct 97 Brain 1997;120:1325-37
Movement, head and eye Jul 96 Ann Neur 1996;39:749-760
" , coordinated Apr 97 Brain 1997;120:91-102
" , " Jun 97 Brain 1997;120:593-604
" , " Aug 97 Brain 1997;120:963-976
" , diagnostic May 97 Arch Neur 1997;54:450-454
" , guidance Aug 97 Brain 1997;120:977-990
MPTP Dec 94 Ann Neur 1994;36:765-770
" Jan 97 J Neurosci 1996;16:7776-7782
" Feb 97 Neur 1996;47:Supp 3
Multiple System AtrophyMar 95 Ann Neur 1995;37:204-210
" Sep 95 J Neur N'surg Psych 1995;59:144-151
" Sep 97 J Clin Neuropharm 1997;20:239-244
Muscle, sound from Apr 97 Lancet 22 Feb 97;533-535
Nerve Growth Factor Apr 96 J Neurosurg 1996;84:685-689
" Nov 96 J Neurosci 1996;16:5437-5442
" Nov 96 J Neurosci 1996;16:6433-6442
" Jul 97 J Neurosurg 1997;86:511-518
" and diabetes Nov 96 Lancet 19 Oct 96:1044-45
Neuroleptics (risk) Mar 96 J Neur N'surg Psych 1996;60:213-216
Neuropeptides Sep 96 Brain 1996;119:823-830
Neurosciences Inst. Dec 95 Science 27 Oct 1995:572
Neurotrophic factors Oct 96 Ann Neur 1996;40:346
" problems Jul 97 Nat Med 1997;3:497
" (BDNF) May 97 J Neurosci 1997;17:2295=2313
Neurotrophic (GDNF) Apr 96 WSJ 21 Mar 1996:
" Jan 97 N Neurosci 16:8132-8139
NMDA antagonist Nov 96 J Neurosci 1996;16:4231-39
" May 97 J Neurosci 1997;17:2921-2927
Nurr-1 May 97 Science 11 Apr 97:248-50
" , editorial May 97 Science 11 Apr 97:202
Nutrients and PD Oct 96 Neur 1996;47:644-650
Olfaction and PD Jul 97 J Neur N'surg Psych 1997;62:436-446
Ondansetron (Zofran) Oct 95 Neur 1995;45:1305-1308
" Feb 97 Neur 1996;47:1608-1609
" , for tremor Apr 97 J Neur N'Surg Psych 1997;62:282-284
On-off effect Dec 95 J Neur N'surg Psych 1995;59:555
" Aug 96 J Neur N'surg Psych 1996;61:634-637
Onset, early vs late Aug 97 Mov Disord 1997;12:277-284
Oxidative stress May 95 Neur 1995;45S3:55
" Aug 95 J Neur N'surg Psych 1995;59:90-91
" Apr 96 Ann Neur 1996;39:378-381
Pallidopyramidal Feb 96 Ann Neur 1995;38:954-956
Pallidotomy, boom in Mar 95 WSJ 22 Feb 95:1
" , benefits Jun 96 Neur 1995;45:753-761
" , " Jul 96 Lancet 25 May 96;1490
" , " Jul 96 Ann Neur 1996;39:826
" , " Apr 97 J Neur N'surg Psych 1997;62:125-132
" , " Apr 97 Lancet 15 Mar 1997:777
" , " Jun 97 Neur 1997;48:1273-1277
" , " Jul 97 Ann Neur 1997;41:834
" , " Oct 97 Arch Neur 1997;54:1026-1029
" , " Oct 97 J Neurosurg 1997;87:358-367
" , cognition Sep 97 Arch Neur 1997;54:947-950
" and DBS Jul 97 Nat Med 1997;3:671-674
" " " Jul 97 Nat Med 1997;3:602-603
" , effects Oct 97 J Neur N'surg Psych 1997;63:150-162
" , gamma knife Jun 96 Ann Neur 1996;39:535-538
" , history Oct 96 Ann Neur 1996;40:341-343
" , low-cost Jul 97 Brain 1997;120:729-737
" , PET scan Jul 95 Ann Neur 1995;37:776-783
" , " Jun 96 Ann Neur 1996;39:450-459
" , " Oct 97 Brain
1997;120:1301-13
" , " Oct 97 Brain 1997;120:1315-24
" , success Oct 96 Ann Neur 1996;40:355-366
" , technique Jul 96 J Neurosurg 1996;84:194-202
" , " Jan 97 J Neurosurg 1996;85:1005-1012
" , " Aug 97 J Neurosurg 1997:87:52-59
Paroxetine (Paxil) Jan 95 Neur 1994;44:2406
Pathways, neural May 95 Neur 1995;45S3:S28-S34
" Nov 96 Neur 1996;1032-1036
Perception, visual May 96 Brain 1996;119:79-87
Pergolide (Permax) May 95 Neur 1995;45S3:S5
" May 95 Neur 1995;45S3:S13-S21
" May 95 Neur 1995;45S3:S22-S27
" Aug 97 Mov Disord 1997;12:402-407
Personality and PD Mar 97 Lancet 15 Feb 97:478
PET diagnosis Dec 94 Ann Neur 1994;36:759-764
" Dec 94 Ann Neur 1994;2:176-182
" Jan 96 J Neur N'surg Psych 1995;59:597-600
" Feb 96 Neur 1995;45:1995-2004
" Jun 96 Ann Neur 1996;39:450-459
" Jun 96 Neur 1996;46:1430-1436
" Jun 96 Neur 1996;46:1200-1205
" Jun 96 Ann Neur 1996;39:650-658
" Jul 96 Brain 1996;119:585-591
" Sep 96 Neur 1996;47:462-466
" Mar 97 Ann Neur 1996;40:873-884
" Mar 97 Ann Neur 1997;41:58-64
" scans, questioned May 97 Science 11 Apr 97:196-198
Porphyria and PD drugs Jul 97 J Neur N'surg Psych 1997;62:562
Post-encephalitis Oct 97 Ann Neur 1997;42:356-359
Pramipexole Apr 96 PDF Newsletter Spr 1996:1
" Aug 97 JAMA 9 Jul 87:125-130
" Aug 97 Neur 1997;49:162-168
" Oct 97 Neur 1997;49:724-728
Prevalence Mar 97 J Neur N'surg Psych 1997;62:10-15
Prions May 96 Science News 13 Apr 1996;228
Progenitor cells Nov 95 Eng. & Sci Sept 95:26
Progression (case hist)Feb 96 NEJM 1996;334:116-118
" Apr 96 JAMA 6 Mar 1996:716
" Nov 96 JAMA 9 Oct 1196;1171
" , in putamen Mar 97 Brain 1996;119:2097-103
Progressive Supranuc. Jun 96 J Neur N'surg Psych 1996;60:589
" Aug 96 J Neur N'surg Psych 1996;61:615-620
" Sep 96 Neur 1996;47:1-9
" Sep 96 Neur 1996;47:148-154
" Apr 97 Brain 1997;120:65-74
" Oct 97 Arch Neur 1997;54:1104-1108
Propranolol Jul 96 Neur 1996;46:1548-1551
Propath program Oct 96 Arch Neur 1996;53:881-884
Proton Magnetic Res. Apr 97 J Neur N'Surg Psych 1997;62:239-242
Prozac (fluoxetine) Nov 95 Neur 1995;45:1855-1858
Psychogenic PD Sep 95 Arch Neur 1995;52:802-810
Quality of life Aug 96 J Neur N'surg Psych 1996;61:71-74
Raclopride, in PET Feb 97 Mov Disord 1997;12:33-38
Rapid-onset May 97 Neur 1997;49:1066-1069
Rating scale, clinical Sep 97 J Clin Neuropharm 1997;20:183-184
" " Sep 97 J Clin Neuropharm 1997;20:322-327
Reaction time Dec 95 J Neur N'surg Psych 1995;59:499-506
" Jan 97 Brain 1996;119:1689-1704
Reflex blink, and PD Dec 96 J Neurosci 1996;16:7308-7330
Regeneration, brain Apr 96 Lancet 16 Mar 1996:751
" Oct 96 Science News 21 Sep 1996:180
" Apr 97 Science 28 Feb 97;1318-19
" , spinal cord Oct 96 Lancet 21 Sep 1996:814
Registry (surveys) Feb 96 Neur 1995;45:1991-1995
" Feb 96 NEJM 1996;334:71-76
" Feb 96 Neur 1995;45:2143-2146
" Feb 96 Arch Neur 1996;53:66-71
Research priorities Nov 95 JAMA 25 Oct 95:1257-8
Response time, levodopaJun 96 Neur 1996;46:1055-1058
" Jun 96 Neur 1996;46:1059-1062
Restless leg syndrome Feb 96 JAMA 17 Jan 1996:
" Feb 97 Neur 1996;47:1435-1441
" May 97 J Clin Neuropharm 1997;20:148-151
" Aug 97 Mov Disord 1997;12:402-407
Rigidity Feb 97 Mov Disord 1997;12:24-32
Risperidone Feb 97 Mov Disord 1997;12:119-121
" Sep 97 Mov Disord 1997;12:610-612
Ropinirole Oct 97 Neur 1997;49:393-399
Salsolinol Aug 96 Ann Neur 1996;40:119-122
Selegiline, amphetamineOct 95 Lancet 1995;346:64
" , and AD May 97 NEJM 14 Apr 97:1216-22
" , benefits Feb 95 Ann Neur 1995;37:95-98
" , " May 97 Mov Disord 1997;12:175-182
" , " Jul 97 Ann Neur 1997;41:833-834
" , DATATOP Apr 95 Arch Neur 1995;52:237-245
" , " Nov 95 Arch Neur 1995;52:564-570
" , " Mar 96 Ann Neur 1996;39:37-45
" , " Mar 96 Ann Neur 1996;39:29-36
" , dosage Aug 97 Mov Disord 1997;12:293-296
" , in favor of Apr 96 PDF Newsletter Spr 1996:2
" , PET scan Dec 94 Ann Neur 1994;36:759-764
" , pro and con Apr 96 BMJ 16 Mar 96:702-705
" , " " " Sep 96 Ann Neur 1996;40:266-269
" , " " " Mar 97 Ann Neur 1997;41:282-283
" , protection by Jan 96 Ann Neur 1995;38:771-777
" " Aug 97 J Neurochem 1997;68:33-39
" " Aug 97 J Neurochem 1997;68:434-436
" , risks of Jan 96 BMJ 16 Dec 95:1602-7
" , " Mar 97 Ann Neur 1996;40:841-845
" , " Apr 97 Neur 1997;48:662-667
" , " Sep 97 J Clin Neuropharm 1997;20:276-278
" , " Oct 97 J Neur N'surg Psych 1997;63:228-234
", special review Feb 97 Neur 1996;47:Supp 3
Serotonin syndrome Mar 97 Neur 1997;48:1070-1077
" antagonist Sep 97 J Clin Neuropharm 1997;20:300-310
Shy-Drager Mar 95 Ann Neur 1995;37:204-210
Sinemet, dissolved Sep 97 Mov Disord 1997;12:608-610
Sinemet CR Jul 95 J Neur N'surg Psych 1995;58:ad
" Dec 95 Lancet 11 Nov 1995;1290
Sjogren's syndrome Feb 97 Mov Disord 1997;12:121-123
Sleep, violence in Jun 97 Lancet 19 Apr 97;1150
" , benefit Sep 97 Mov Disord 1997;12:506-508
Smell, loss of Jul 97 J Neur N'surg Psych 1997;62:436-446
Smoking and PD Sep 95 Neur 1995;45:1041
" Oct 95 Neur 1995;58:294-298
" Apr 96 Time 11 Mar 1996:60
" Apr 96 Lancet 24 Feb 1996:527
" Apr 96 Ann Neur 1996;39:378-381
" Jun 96 Neur 1996;46:1275-1284
SPECT, diagnosis by Apr 96 Neur 1996;46:278-285
" Apr 96 Neur 1996;46:231-237
" Apr 97 Brain 1997;120:103-110
" Apr 97 J Neur N'surg Psych 1997;62:133-140
Speech therapy Feb 97 Neur 1996;47:1496-1504
Stem cells, cultured Aug 97 Science News 19 Jul 97:36
" , review of May 97 Science 4 Apr 1997:66-71
Stereotactic Aug 95 J Neurosurg 1995;83:197-205
" Apr 96 Science News 30 Mar 1996:204
Stimulation, chronic Jun 96 Neur 1996;46:1150-1153
" Oct 96 Arch Neur 1996;53:898-903
Strategy, summary May 97 J Clin Neuropharm 1997;20:95-115
Strength, arm Mar 96 Ann Neur 1996;39:79-88
" Jun 97 Brain 1997;120:401-408
Striatonigral degener- Nov 96 Neur 1996;47:1032-1036
Stroke, help from Feb 97 Mov Disord 1997;12:124-126
" , adverse effect Apr 97 J Neur N'surg Psych 1997;62:288-289
" , " Oct 97 Neur 1997;49:707-710
Surgery, summary Mar 97 J Neur N'surg Psych 1997;62:2-8
Swallowing Mar 97 Neur 1997;48:373-375
" Aug 97 Mov Disord 1977;12:322-327
Sweats, control of Mar 95 Ann Neur 1995;37:120-122
Symmetrel (Amantadine) Jul 96 Neur 1996;46:1551-1556
Tachyphemia Aug 97 Mov Disord 1997;12:302-305
Tacrine, PD symptoms Oct 96 J Neur N'surg Psych 1996;61:324-325
Tactile acuity Aug 97 Neur 1997;49:168-177
Tardive dyskinesia Feb 97 Mov Disord 1997;12:119-121
" " , and PVP Apr 97 Lancet 15 Mar 1997:777
Tetanus shot caused Oct 97 J Neur N'surg Psych 1997;63:258
Thalamotomy Jun 96 J Neur N'surg Psych 1996;60:564-571
" Jan 97 Brain 1996;119:1717-27
" Mar 97 Ann Neur 1997;41:108-111
Thalamus, and tremor Mar 96 Neur 1996;46:75-79
" Jun 96 Neur 1996;46:1150-1153
Therapy, tutorial Jul 96 Western J Med 1994;161:303-308
" Jul 96 Postgrad Med 1996;99:52-68
Time, judgement of Mar 96 Science News 17 Feb 1996:101
" May 96 Brain 1996;119:51-70
Tolcapone Feb 97 Neur 1997;48:81-87
" Oct 97 Lancet 6 Sep 1997:712
Toxins, Environmental Dec 94 Ann Neur 1994;36:765-770
" Apr 95 Neur 1995;45:435-439
" Feb 96 Neur 1995'45:2112
" Jul 97 Neur 1997;48:1583-1588
Tracking, visual Jun 95 Brain 1995;118:485-493
Transcranial mag. stim May 97 J Neurosci 1997;17:3178-3184
" Aug 97 Mov Disord 1997;12:315-321
Tremor, resting PD Jun 96 Neur 1996;46:1359-1370
", cerebellar Apr 97 J Neur N'surg Psych 1997;62:282-284
", surgery for May 97 J Neurosurg 1997;86:642-647
Tourette Syndrome Aug 97 Mov Disord 1997:12:402-407
Ubiquitin Feb 96 Brain 1995;118:1447-49
Urinary dysfunction Jul 97 J Neur N'surg Psych 1997;62:507-511
" " Sep 97 Mov Disord 1997;12:509-513
Valproate Oct 96 Neur 1996;47:626-635
Visual perception May 96 Brain 1996;119:79-87
Vision abnormality Oct 95 Neur 1995;45:1144-1148
Visuospatial attention Jun 95 Brain 1995;118:153-166
Weight loss Feb 97 Neur 1997;48:88-91
Wine and dementia May 97 BMJ 5 Apr 97:997
Young onset Sep 96 Neur 1996;47:225-230
" " Aug 97 Mov Disord 1997;12:277-284
Zolpidem Jun 97 Lancet 26 Apr 97;1222-23
" Aug 97 Lancet 5 Jul 97;74
--
J. R. Bruman (818) 789-3694
3527 Cody Road
Sherman Oaks, CA 91403-5013
|
